Featured Story Using AI to Reduce Delirium in the ICU
Pilot study will explore whether AI headset can help reduce delirium and delay post-delirium cognitive decline.
Pilot study will explore whether AI headset can help reduce delirium and delay post-delirium cognitive decline.
Johns Hopkins psychiatry researcher Andrew Huhn tests the anti-wakefulness medication suvorexant in $18 million clinical trial.
Johns Hopkins researchers will study the connection between PMD and inflammation.
"Everyone experiences pain differently," says Johns Hopkins psychiatrist Traci Speed.
Providing personalized care for patients of all ages, psychiatrist Azin Bekhrad also treats individuals who have difficulties following a psychedelic experience.